Green Thumb Industries Inc.
Green Thumb Industries Inc. (GTBIF) Stock Competitors & Peer Comparison
See (GTBIF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GTBIF | $5.99 | +3.81% | 1.4B | 27.71 | $0.21 | N/A |
| MKGAF | $137.00 | +1.84% | 59.6B | 18.00 | $7.61 | +1.83% |
| MKKGY | $26.81 | +0.07% | 57.6B | 17.71 | $1.51 | +1.87% |
| TKPHF | $29.50 | -8.19% | 46.4B | 65.56 | $0.45 | +4.51% |
| HLNCF | $4.93 | +1.02% | 44.2B | 23.45 | $0.21 | +1.77% |
| IPSEY | $33.00 | +1.79% | 43.7B | 26.61 | $1.24 | +0.79% |
| SDZNY | $60.23 | +0.57% | 26B | -3015.50 | -$0.02 | +1.12% |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| TEVJF | $14.00 | +0.00% | 16.1B | -12.17 | -$1.15 | N/A |
| SGIOY | $8.57 | +0.23% | 14.6B | 12.79 | $0.67 | +1.85% |
Stock Comparison
GTBIF vs MKGAF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, MKGAF has a market cap of 59.6B. Regarding current trading prices, GTBIF is priced at $5.99, while MKGAF trades at $137.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas MKGAF's P/E ratio is 18.00. In terms of profitability, GTBIF's ROE is +0.03%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, GTBIF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check MKGAF's competition here
GTBIF vs MKKGY Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, MKKGY has a market cap of 57.6B. Regarding current trading prices, GTBIF is priced at $5.99, while MKKGY trades at $26.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas MKKGY's P/E ratio is 17.71. In terms of profitability, GTBIF's ROE is +0.03%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, GTBIF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check MKKGY's competition here
GTBIF vs TKPHF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, TKPHF has a market cap of 46.4B. Regarding current trading prices, GTBIF is priced at $5.99, while TKPHF trades at $29.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas TKPHF's P/E ratio is 65.56. In terms of profitability, GTBIF's ROE is +0.03%, compared to TKPHF's ROE of +0.01%. Regarding short-term risk, GTBIF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check TKPHF's competition here
GTBIF vs HLNCF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, HLNCF has a market cap of 44.2B. Regarding current trading prices, GTBIF is priced at $5.99, while HLNCF trades at $4.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas HLNCF's P/E ratio is 23.45. In terms of profitability, GTBIF's ROE is +0.03%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, GTBIF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check HLNCF's competition here
GTBIF vs IPSEY Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, IPSEY has a market cap of 43.7B. Regarding current trading prices, GTBIF is priced at $5.99, while IPSEY trades at $33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas IPSEY's P/E ratio is 26.61. In terms of profitability, GTBIF's ROE is +0.03%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, GTBIF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check IPSEY's competition here
GTBIF vs SDZNY Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, SDZNY has a market cap of 26B. Regarding current trading prices, GTBIF is priced at $5.99, while SDZNY trades at $60.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas SDZNY's P/E ratio is -3015.50. In terms of profitability, GTBIF's ROE is +0.03%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, GTBIF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check SDZNY's competition here
GTBIF vs ESALY Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, GTBIF is priced at $5.99, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas ESALY's P/E ratio is 20.54. In terms of profitability, GTBIF's ROE is +0.03%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, GTBIF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check ESALY's competition here
GTBIF vs TEVJF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, TEVJF has a market cap of 16.1B. Regarding current trading prices, GTBIF is priced at $5.99, while TEVJF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas TEVJF's P/E ratio is -12.17. In terms of profitability, GTBIF's ROE is +0.03%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, GTBIF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check TEVJF's competition here
GTBIF vs SGIOY Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, SGIOY has a market cap of 14.6B. Regarding current trading prices, GTBIF is priced at $5.99, while SGIOY trades at $8.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas SGIOY's P/E ratio is 12.79. In terms of profitability, GTBIF's ROE is +0.03%, compared to SGIOY's ROE of +0.05%. Regarding short-term risk, GTBIF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check SGIOY's competition here
GTBIF vs SGIOF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, SGIOF has a market cap of 13.8B. Regarding current trading prices, GTBIF is priced at $5.99, while SGIOF trades at $16.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas SGIOF's P/E ratio is 12.00. In terms of profitability, GTBIF's ROE is +0.03%, compared to SGIOF's ROE of +0.05%. Regarding short-term risk, GTBIF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check SGIOF's competition here
GTBIF vs BIOVF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, BIOVF has a market cap of 10.3B. Regarding current trading prices, GTBIF is priced at $5.99, while BIOVF trades at $29.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas BIOVF's P/E ratio is 22.57. In terms of profitability, GTBIF's ROE is +0.03%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, GTBIF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check BIOVF's competition here
GTBIF vs IPSEF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, GTBIF is priced at $5.99, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas IPSEF's P/E ratio is 22.67. In terms of profitability, GTBIF's ROE is +0.03%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, GTBIF is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check IPSEF's competition here
GTBIF vs ESAIY Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, ESAIY has a market cap of 8B. Regarding current trading prices, GTBIF is priced at $5.99, while ESAIY trades at $7.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas ESAIY's P/E ratio is 25.25. In terms of profitability, GTBIF's ROE is +0.03%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, GTBIF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check ESAIY's competition here
GTBIF vs SFOSF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, SFOSF has a market cap of 7.6B. Regarding current trading prices, GTBIF is priced at $5.99, while SFOSF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas SFOSF's P/E ratio is 13.03. In terms of profitability, GTBIF's ROE is +0.03%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, GTBIF is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check SFOSF's competition here
GTBIF vs ESALF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, ESALF has a market cap of 7.2B. Regarding current trading prices, GTBIF is priced at $5.99, while ESALF trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas ESALF's P/E ratio is 23.26. In terms of profitability, GTBIF's ROE is +0.03%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, GTBIF is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check ESALF's competition here
GTBIF vs HKMPF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, HKMPF has a market cap of 6.2B. Regarding current trading prices, GTBIF is priced at $5.99, while HKMPF trades at $27.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas HKMPF's P/E ratio is 17.37. In terms of profitability, GTBIF's ROE is +0.03%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, GTBIF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check HKMPF's competition here
GTBIF vs HKMPY Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, HKMPY has a market cap of 6.1B. Regarding current trading prices, GTBIF is priced at $5.99, while HKMPY trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas HKMPY's P/E ratio is 17.08. In terms of profitability, GTBIF's ROE is +0.03%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, GTBIF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check HKMPY's competition here
GTBIF vs GZPHF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, GTBIF is priced at $5.99, while GZPHF trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas GZPHF's P/E ratio is 10.35. In terms of profitability, GTBIF's ROE is +0.03%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, GTBIF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check GZPHF's competition here
GTBIF vs SGFEF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, GTBIF is priced at $5.99, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas SGFEF's P/E ratio is 24.75. In terms of profitability, GTBIF's ROE is +0.03%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, GTBIF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check SGFEF's competition here
GTBIF vs WIBFF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, GTBIF is priced at $5.99, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, GTBIF's ROE is +0.03%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, GTBIF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check WIBFF's competition here
GTBIF vs HLBBF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, HLBBF has a market cap of 4.2B. Regarding current trading prices, GTBIF is priced at $5.99, while HLBBF trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas HLBBF's P/E ratio is 10.25. In terms of profitability, GTBIF's ROE is +0.03%, compared to HLBBF's ROE of +0.14%. Regarding short-term risk, GTBIF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check HLBBF's competition here
GTBIF vs CHSYF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, CHSYF has a market cap of 3.7B. Regarding current trading prices, GTBIF is priced at $5.99, while CHSYF trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas CHSYF's P/E ratio is 16.85. In terms of profitability, GTBIF's ROE is +0.03%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, GTBIF is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check CHSYF's competition here
GTBIF vs LVZPF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, LVZPF has a market cap of 3.5B. Regarding current trading prices, GTBIF is priced at $5.99, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, GTBIF's ROE is +0.03%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, GTBIF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check LVZPF's competition here
GTBIF vs HLUBF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, HLUBF has a market cap of 3.4B. Regarding current trading prices, GTBIF is priced at $5.99, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas HLUBF's P/E ratio is 7.12. In terms of profitability, GTBIF's ROE is +0.03%, compared to HLUBF's ROE of +0.14%. Regarding short-term risk, GTBIF is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check HLUBF's competition here
GTBIF vs ULIHF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, ULIHF has a market cap of 3.4B. Regarding current trading prices, GTBIF is priced at $5.99, while ULIHF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas ULIHF's P/E ratio is 9.25. In terms of profitability, GTBIF's ROE is +0.03%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, GTBIF is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check ULIHF's competition here
GTBIF vs APNHF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, GTBIF is priced at $5.99, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas APNHF's P/E ratio is 12.72. In terms of profitability, GTBIF's ROE is +0.03%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, GTBIF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check APNHF's competition here
GTBIF vs APNHY Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, APNHY has a market cap of 3.1B. Regarding current trading prices, GTBIF is priced at $5.99, while APNHY trades at $6.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas APNHY's P/E ratio is 12.43. In terms of profitability, GTBIF's ROE is +0.03%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, GTBIF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check APNHY's competition here
GTBIF vs SMDPY Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, SMDPY has a market cap of 3.1B. Regarding current trading prices, GTBIF is priced at $5.99, while SMDPY trades at $7.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas SMDPY's P/E ratio is 19.42. In terms of profitability, GTBIF's ROE is +0.03%, compared to SMDPY's ROE of +0.15%. Regarding short-term risk, GTBIF is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check SMDPY's competition here
GTBIF vs HYPMY Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, HYPMY has a market cap of 3.1B. Regarding current trading prices, GTBIF is priced at $5.99, while HYPMY trades at $4.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas HYPMY's P/E ratio is 21.17. In terms of profitability, GTBIF's ROE is +0.03%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, GTBIF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check HYPMY's competition here
GTBIF vs INVVY Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, GTBIF is priced at $5.99, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas INVVY's P/E ratio is -62.42. In terms of profitability, GTBIF's ROE is +0.03%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, GTBIF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check INVVY's competition here
GTBIF vs IZQVF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, GTBIF is priced at $5.99, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, GTBIF's ROE is +0.03%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, GTBIF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check IZQVF's competition here
GTBIF vs DNPUF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, DNPUF has a market cap of 2.9B. Regarding current trading prices, GTBIF is priced at $5.99, while DNPUF trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas DNPUF's P/E ratio is 18.10. In terms of profitability, GTBIF's ROE is +0.03%, compared to DNPUF's ROE of +0.15%. Regarding short-term risk, GTBIF is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check DNPUF's competition here
GTBIF vs LBTSF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, GTBIF is priced at $5.99, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas LBTSF's P/E ratio is 102.77. In terms of profitability, GTBIF's ROE is +0.03%, compared to LBTSF's ROE of +0.02%. Regarding short-term risk, GTBIF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check LBTSF's competition here
GTBIF vs HMDCF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, GTBIF is priced at $5.99, while HMDCF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, GTBIF's ROE is +0.03%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, GTBIF is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check HMDCF's competition here
GTBIF vs THCBF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, GTBIF is priced at $5.99, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas THCBF's P/E ratio is -0.10. In terms of profitability, GTBIF's ROE is +0.03%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, GTBIF is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check THCBF's competition here
GTBIF vs DMPHF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, GTBIF is priced at $5.99, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, GTBIF's ROE is +0.03%, compared to DMPHF's ROE of +0.17%. Regarding short-term risk, GTBIF is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check DMPHF's competition here
GTBIF vs HTSUF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, GTBIF is priced at $5.99, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas HTSUF's P/E ratio is 16.17. In terms of profitability, GTBIF's ROE is +0.03%, compared to HTSUF's ROE of +0.08%. Regarding short-term risk, GTBIF is less volatile compared to HTSUF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check HTSUF's competition here
GTBIF vs LJUIF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, GTBIF is priced at $5.99, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, GTBIF's ROE is +0.03%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, GTBIF is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check LJUIF's competition here
GTBIF vs ARSUF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, GTBIF is priced at $5.99, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, GTBIF's ROE is +0.03%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, GTBIF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check ARSUF's competition here
GTBIF vs TSMRF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, TSMRF has a market cap of 1.8B. Regarding current trading prices, GTBIF is priced at $5.99, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas TSMRF's P/E ratio is 8.19. In terms of profitability, GTBIF's ROE is +0.03%, compared to TSMRF's ROE of +0.11%. Regarding short-term risk, GTBIF is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check TSMRF's competition here
GTBIF vs NPNKF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, GTBIF is priced at $5.99, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas NPNKF's P/E ratio is 7.85. In terms of profitability, GTBIF's ROE is +0.03%, compared to NPNKF's ROE of +0.14%. Regarding short-term risk, GTBIF is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check NPNKF's competition here
GTBIF vs MITPF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, GTBIF is priced at $5.99, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas MITPF's P/E ratio is -10.81. In terms of profitability, GTBIF's ROE is +0.03%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, GTBIF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check MITPF's competition here
GTBIF vs KARBF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, GTBIF is priced at $5.99, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas KARBF's P/E ratio is 262.50. In terms of profitability, GTBIF's ROE is +0.03%, compared to KARBF's ROE of N/A. Regarding short-term risk, GTBIF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check KARBF's competition here
GTBIF vs EVOTF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, GTBIF is priced at $5.99, while EVOTF trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas EVOTF's P/E ratio is -6.26. In terms of profitability, GTBIF's ROE is +0.03%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, GTBIF is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check EVOTF's competition here
GTBIF vs CASBF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, CASBF has a market cap of 1.5B. Regarding current trading prices, GTBIF is priced at $5.99, while CASBF trades at $4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas CASBF's P/E ratio is -23.33. In terms of profitability, GTBIF's ROE is +0.03%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, GTBIF is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check CASBF's competition here
GTBIF vs SHEZF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, SHEZF has a market cap of 1.4B. Regarding current trading prices, GTBIF is priced at $5.99, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, GTBIF's ROE is +0.03%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, GTBIF is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check SHEZF's competition here
GTBIF vs NPPNY Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, GTBIF is priced at $5.99, while NPPNY trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas NPPNY's P/E ratio is 6.59. In terms of profitability, GTBIF's ROE is +0.03%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, GTBIF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check NPPNY's competition here
GTBIF vs CHIZF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, GTBIF is priced at $5.99, while CHIZF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas CHIZF's P/E ratio is 13.75. In terms of profitability, GTBIF's ROE is +0.03%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, GTBIF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check CHIZF's competition here
GTBIF vs SWGHF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, GTBIF is priced at $5.99, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, GTBIF's ROE is +0.03%, compared to SWGHF's ROE of +0.12%. Regarding short-term risk, GTBIF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check SWGHF's competition here
GTBIF vs KSPHF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, GTBIF is priced at $5.99, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas KSPHF's P/E ratio is 14.66. In terms of profitability, GTBIF's ROE is +0.03%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, GTBIF is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check KSPHF's competition here
GTBIF vs GNMLF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, GTBIF is priced at $5.99, while GNMLF trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas GNMLF's P/E ratio is 9.08. In terms of profitability, GTBIF's ROE is +0.03%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, GTBIF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check GNMLF's competition here
GTBIF vs KKPCF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, GTBIF is priced at $5.99, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas KKPCF's P/E ratio is 11.33. In terms of profitability, GTBIF's ROE is +0.03%, compared to KKPCF's ROE of +0.09%. Regarding short-term risk, GTBIF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check KKPCF's competition here
GTBIF vs CURLF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, CURLF has a market cap of 963.2M. Regarding current trading prices, GTBIF is priced at $5.99, while CURLF trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas CURLF's P/E ratio is -3.82. In terms of profitability, GTBIF's ROE is +0.03%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, GTBIF is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check CURLF's competition here
GTBIF vs BIOGY Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, BIOGY has a market cap of 960.3M. Regarding current trading prices, GTBIF is priced at $5.99, while BIOGY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas BIOGY's P/E ratio is 32.50. In terms of profitability, GTBIF's ROE is +0.03%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, GTBIF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check BIOGY's competition here
GTBIF vs SHPHF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, GTBIF is priced at $5.99, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, GTBIF's ROE is +0.03%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, GTBIF is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check SHPHF's competition here
GTBIF vs LVTTF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, LVTTF has a market cap of 901.7M. Regarding current trading prices, GTBIF is priced at $5.99, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, GTBIF's ROE is +0.03%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, GTBIF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check LVTTF's competition here
GTBIF vs EVRRF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, EVRRF has a market cap of 897.8M. Regarding current trading prices, GTBIF is priced at $5.99, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, GTBIF's ROE is +0.03%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, GTBIF is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check EVRRF's competition here
GTBIF vs TCNNF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, TCNNF has a market cap of 863.9M. Regarding current trading prices, GTBIF is priced at $5.99, while TCNNF trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas TCNNF's P/E ratio is -5.72. In terms of profitability, GTBIF's ROE is +0.03%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, GTBIF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check TCNNF's competition here
GTBIF vs NRXCF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, NRXCF has a market cap of 851.8M. Regarding current trading prices, GTBIF is priced at $5.99, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, GTBIF's ROE is +0.03%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, GTBIF is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check NRXCF's competition here
GTBIF vs TWAPF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, GTBIF is priced at $5.99, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, GTBIF's ROE is +0.03%, compared to TWAPF's ROE of +0.11%. Regarding short-term risk, GTBIF is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check TWAPF's competition here
GTBIF vs SWDCF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, SWDCF has a market cap of 773.6M. Regarding current trading prices, GTBIF is priced at $5.99, while SWDCF trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas SWDCF's P/E ratio is 121.00. In terms of profitability, GTBIF's ROE is +0.03%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, GTBIF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check SWDCF's competition here
GTBIF vs CSWYF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, GTBIF is priced at $5.99, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, GTBIF's ROE is +0.03%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, GTBIF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check CSWYF's competition here
GTBIF vs NIKA Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, NIKA has a market cap of 708.2M. Regarding current trading prices, GTBIF is priced at $5.99, while NIKA trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas NIKA's P/E ratio is N/A. In terms of profitability, GTBIF's ROE is +0.03%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, GTBIF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check NIKA's competition here
GTBIF vs TRXPF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, GTBIF is priced at $5.99, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, GTBIF's ROE is +0.03%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, GTBIF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check TRXPF's competition here
GTBIF vs YIHCF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, GTBIF is priced at $5.99, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, GTBIF's ROE is +0.03%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, GTBIF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check YIHCF's competition here
GTBIF vs TRSSF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, GTBIF is priced at $5.99, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, GTBIF's ROE is +0.03%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, GTBIF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check TRSSF's competition here
GTBIF vs ELTP Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, ELTP has a market cap of 580.4M. Regarding current trading prices, GTBIF is priced at $5.99, while ELTP trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas ELTP's P/E ratio is -27.10. In terms of profitability, GTBIF's ROE is +0.03%, compared to ELTP's ROE of -0.09%. Regarding short-term risk, GTBIF is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check ELTP's competition here
GTBIF vs AIHLF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, AIHLF has a market cap of 566M. Regarding current trading prices, GTBIF is priced at $5.99, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas AIHLF's P/E ratio is 12.07. In terms of profitability, GTBIF's ROE is +0.03%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, GTBIF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check AIHLF's competition here
GTBIF vs PKBFF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, PKBFF has a market cap of 550.7M. Regarding current trading prices, GTBIF is priced at $5.99, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas PKBFF's P/E ratio is N/A. In terms of profitability, GTBIF's ROE is +0.03%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, GTBIF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check PKBFF's competition here
GTBIF vs CCHWF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, GTBIF is priced at $5.99, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, GTBIF's ROE is +0.03%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, GTBIF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check CCHWF's competition here
GTBIF vs BOIRF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, BOIRF has a market cap of 494.8M. Regarding current trading prices, GTBIF is priced at $5.99, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, GTBIF's ROE is +0.03%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, GTBIF is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check BOIRF's competition here
GTBIF vs PEXXF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, GTBIF is priced at $5.99, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, GTBIF's ROE is +0.03%, compared to PEXXF's ROE of N/A. Regarding short-term risk, GTBIF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check PEXXF's competition here
GTBIF vs KHTRF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, KHTRF has a market cap of 448.4M. Regarding current trading prices, GTBIF is priced at $5.99, while KHTRF trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas KHTRF's P/E ratio is 64.29. In terms of profitability, GTBIF's ROE is +0.03%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, GTBIF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check KHTRF's competition here
GTBIF vs AGYTF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, GTBIF is priced at $5.99, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, GTBIF's ROE is +0.03%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, GTBIF is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check AGYTF's competition here
GTBIF vs HUMDF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, GTBIF is priced at $5.99, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, GTBIF's ROE is +0.03%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, GTBIF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check HUMDF's competition here
GTBIF vs BHCCF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, BHCCF has a market cap of 271.6M. Regarding current trading prices, GTBIF is priced at $5.99, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, GTBIF's ROE is +0.03%, compared to BHCCF's ROE of +0.19%. Regarding short-term risk, GTBIF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check BHCCF's competition here
GTBIF vs GLASF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, GLASF has a market cap of 269.1M. Regarding current trading prices, GTBIF is priced at $5.99, while GLASF trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas GLASF's P/E ratio is -57.67. In terms of profitability, GTBIF's ROE is +0.03%, compared to GLASF's ROE of +0.07%. Regarding short-term risk, GTBIF is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check GLASF's competition here
GTBIF vs CPHRF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, CPHRF has a market cap of 233.8M. Regarding current trading prices, GTBIF is priced at $5.99, while CPHRF trades at $9.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas CPHRF's P/E ratio is 25.34. In terms of profitability, GTBIF's ROE is +0.03%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, GTBIF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check CPHRF's competition here
GTBIF vs CRLBF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, CRLBF has a market cap of 212.3M. Regarding current trading prices, GTBIF is priced at $5.99, while CRLBF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas CRLBF's P/E ratio is -2.62. In terms of profitability, GTBIF's ROE is +0.03%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, GTBIF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check CRLBF's competition here
GTBIF vs VRNOF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, VRNOF has a market cap of 209M. Regarding current trading prices, GTBIF is priced at $5.99, while VRNOF trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas VRNOF's P/E ratio is -0.58. In terms of profitability, GTBIF's ROE is +0.03%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, GTBIF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check VRNOF's competition here
GTBIF vs PLNHF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, GTBIF is priced at $5.99, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, GTBIF's ROE is +0.03%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, GTBIF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check PLNHF's competition here
GTBIF vs PHCUF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, PHCUF has a market cap of 159.9M. Regarding current trading prices, GTBIF is priced at $5.99, while PHCUF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas PHCUF's P/E ratio is 600.00. In terms of profitability, GTBIF's ROE is +0.03%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, GTBIF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check PHCUF's competition here
GTBIF vs CBWTF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, CBWTF has a market cap of 144M. Regarding current trading prices, GTBIF is priced at $5.99, while CBWTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas CBWTF's P/E ratio is 5.39. In terms of profitability, GTBIF's ROE is +0.03%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, GTBIF is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check CBWTF's competition here
GTBIF vs COPHF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, GTBIF is priced at $5.99, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas COPHF's P/E ratio is -0.02. In terms of profitability, GTBIF's ROE is +0.03%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, GTBIF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check COPHF's competition here
GTBIF vs STMH Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, STMH has a market cap of 127.1M. Regarding current trading prices, GTBIF is priced at $5.99, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas STMH's P/E ratio is N/A. In terms of profitability, GTBIF's ROE is +0.03%, compared to STMH's ROE of -2.75%. Regarding short-term risk, GTBIF is more volatile compared to STMH. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check STMH's competition here
GTBIF vs NWPN Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, GTBIF is priced at $5.99, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas NWPN's P/E ratio is -0.04. In terms of profitability, GTBIF's ROE is +0.03%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, GTBIF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check NWPN's competition here
GTBIF vs LOVFF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, LOVFF has a market cap of 120.1M. Regarding current trading prices, GTBIF is priced at $5.99, while LOVFF trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas LOVFF's P/E ratio is 13.14. In terms of profitability, GTBIF's ROE is +0.03%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, GTBIF is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check LOVFF's competition here
GTBIF vs HLTRF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, HLTRF has a market cap of 113.3M. Regarding current trading prices, GTBIF is priced at $5.99, while HLTRF trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas HLTRF's P/E ratio is -6.32. In terms of profitability, GTBIF's ROE is +0.03%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, GTBIF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check HLTRF's competition here
GTBIF vs LPCUF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, GTBIF is priced at $5.99, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, GTBIF's ROE is +0.03%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, GTBIF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check LPCUF's competition here
GTBIF vs CNVCF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, GTBIF is priced at $5.99, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, GTBIF's ROE is +0.03%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, GTBIF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check CNVCF's competition here
GTBIF vs GRUSF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, GRUSF has a market cap of 99.2M. Regarding current trading prices, GTBIF is priced at $5.99, while GRUSF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas GRUSF's P/E ratio is -13.34. In terms of profitability, GTBIF's ROE is +0.03%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, GTBIF is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check GRUSF's competition here
GTBIF vs BIOYF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, BIOYF has a market cap of 96.9M. Regarding current trading prices, GTBIF is priced at $5.99, while BIOYF trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas BIOYF's P/E ratio is 17.24. In terms of profitability, GTBIF's ROE is +0.03%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, GTBIF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check BIOYF's competition here
GTBIF vs JUSHF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, JUSHF has a market cap of 88.5M. Regarding current trading prices, GTBIF is priced at $5.99, while JUSHF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas JUSHF's P/E ratio is -1.80. In terms of profitability, GTBIF's ROE is +0.03%, compared to JUSHF's ROE of +1.06%. Regarding short-term risk, GTBIF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check JUSHF's competition here
GTBIF vs LRDSF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, LRDSF has a market cap of 84.9M. Regarding current trading prices, GTBIF is priced at $5.99, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, GTBIF's ROE is +0.03%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, GTBIF is more volatile compared to LRDSF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check LRDSF's competition here
GTBIF vs AAWH Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, AAWH has a market cap of 83.4M. Regarding current trading prices, GTBIF is priced at $5.99, while AAWH trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas AAWH's P/E ratio is -1.02. In terms of profitability, GTBIF's ROE is +0.03%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, GTBIF is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check AAWH's competition here
GTBIF vs ABSCF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, ABSCF has a market cap of 77.4M. Regarding current trading prices, GTBIF is priced at $5.99, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, GTBIF's ROE is +0.03%, compared to ABSCF's ROE of +0.32%. Regarding short-term risk, GTBIF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check ABSCF's competition here
GTBIF vs EOFBY Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, GTBIF is priced at $5.99, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, GTBIF's ROE is +0.03%, compared to EOFBY's ROE of N/A. Regarding short-term risk, GTBIF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.Check EOFBY's competition here
GTBIF vs DUTV Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, DUTV has a market cap of 71.8M. Regarding current trading prices, GTBIF is priced at $5.99, while DUTV trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas DUTV's P/E ratio is N/A. In terms of profitability, GTBIF's ROE is +0.03%, compared to DUTV's ROE of +0.02%. Regarding short-term risk, GTBIF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check DUTV's competition here
GTBIF vs ORXOF Comparison July 2025
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.4B. In comparison, ORXOF has a market cap of 69.7M. Regarding current trading prices, GTBIF is priced at $5.99, while ORXOF trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 27.71, whereas ORXOF's P/E ratio is -3.11. In terms of profitability, GTBIF's ROE is +0.03%, compared to ORXOF's ROE of +2.89%. Regarding short-term risk, GTBIF is less volatile compared to ORXOF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.Check ORXOF's competition here